OIS is the prime source for Ophthalmic Innovation. We are where live events, podcasts, news, videos and virtual programs come together to unveil leading-edge advancements and make impactful connections between entrepreneurs, start-ups, clinical thought leaders, industry executives and investment professionals.

For Start-Ups & Entrepeneurs

Spread the word on your product and progress, get a competitive advantage, network, raise capital and make invaluable connections.

For Physicians & Clinical Thought Leaders

Share your expertise, learn about medical advisory boards, work on clinical trials, consult companies on the development of a product and have the latest info on the medical technology.

For Executives & Investment Professionals

Network, manage clinical trials, help start-ups go public or raise money, invest in start-ups with the latest and greatest technologies,

Learn More

OIS PODCAST | LATEST NEWS

Finding and Funding Assets in Retina, from OIS Retina@ASRS

October 20, 2021

The Next Cycle of Retinal Surgery Innovation, with Stanley Chang, MD

October 12, 2021

Solving the Dry Eye Mystery With Neurolens’ Jeffrey Krall, OD

October 4, 2021

Following Intellectual Passions, With Dr. Baruch Kupperman

September 29, 2021

Revolutionizing Cataract Surgery from Innovation to Commercialization

September 22, 2021

Nine Days in September: Three Pharma Plays in Gene Therapy

October 20, 2021

OIS Retina@ASRS Sizes Up the Challenges in Retina Innovation

October 12, 2021

Regulatory Pathways Group Has a Plan to Build on Mentor’s Work

October 6, 2021

Solving the Dry Eye Mystery With Neurolens’ Jeffrey Krall, OD

October 4, 2021

In a Busy Summer, Harrow Health Expands Beyond Compounding, Adds DTC Business

September 29, 2021

NIH Awards Amydis $3 Million Grant Award for Novel Amyloid Beta Retinal Tracer Applicable to CNS Diseases

August 10, 2021

Stem Cell-Engineered Implant for Geographic Atrophy Shows Promise, Long-Term Survival of Cells in Early Trial

August 3, 2021

Apellis Building on Its Platform with APL-2 for Geographic Atrophy

June 8, 2021

The Four Trends Driving the Digital Space

May 25, 2021

Innovega is Moving Quickly in Augmented- and Virtual-Reality Space

May 19, 2021

Despite Mixed Trial Results and Stock Plunge, Apellis Keeps Commitment to Lead Candidate Pegcetacoplan

September 15, 2021

From Big Pharma Lawyer to Eye Care Disruptor: IACTA Pharmaceuticals Founder & CEO Damon Burrows

September 15, 2021

NIH Awards Amydis $3 Million Grant Award for Novel Amyloid Beta Retinal Tracer Applicable to CNS Diseases

August 10, 2021

Stem Cell-Engineered Implant for Geographic Atrophy Shows Promise, Long-Term Survival of Cells in Early Trial

August 3, 2021

Apellis Building on Its Platform with APL-2 for Geographic Atrophy

June 8, 2021

Take Me to OIS Podcasts

WOULD YOU LIKE TO BE A GUEST ON OUR PODCAST?

Apply Today

View all events

COMING SOON | STAY TUNED

SUBSCRIBE TO OUR NEWSLETTER AND KEEP AN EYE ON INNOVATION.

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

SUBSCRIBE TODAY